VRX: To Present At UBS Global Life Sciences Conference @ 11:00 ET [delayed] -
Valeant Pharmaceuticals to acquire Coria Laboratories -
DFB Sells Coria Labs to Valeant Pharmaceuticals -
VALEANT PHARMACEUTICALS INTERNATIONAL SAYS EXPECT THIS TRANSACTION WILL BE ACCRE -
Valeant Announces Presentation of Retigabine Data at the 8th European Congress on Epileptology -
Valeant Pharmaceuticals sells certain European business operations to Meda -
BRIEF-Valeant Pharma and GSK announce deal for retigabine -
Valeant Pharmaceuticals Hits Highest Level In Over A Year And A Half On Increased Volume -
Valeant Pharmaceuticals to Present at UBS Global Life Sciences Conference -
VRX hits 52-week high at 20.29 -
Valeant Pharmaceuticals (VRX) NewsBite - VRX Hits 52-Week High -
Valeant Pharmaceuticals Hits Highest Level In A Year And A Half On Increased Volume -
VRX: Q2 Earnings Call @ 11:00 ET Today [delayed] -
Valeant Pharmaceuticals Reports Second Quarter Financial Results -
Meda and Valeant Pharmaceuticals to form JVs -
Meda Enters into Joint Venture with Valeant -
Valeant Announces Agreement to Enter into Joint Venture with Meda -
Valeant to sell certain European business operations to Meda -
VALEANT PHARMACEUTICALS INTERNATIONAL SAYS CENTRAL EUROPEAN OPS EXCLUDED FROM -